Literature DB >> 28591478

Hypothalamic hamartoma: Neuropathology and epileptogenesis.

John F Kerrigan1,2, Angela Parsons2, Candy Tsang2, Kristina Simeone3, Stephen Coons4, Jie Wu5.   

Abstract

Hypothalamic hamartomas (HHs) are congenital malformations of the ventral hypothalamus resulting in treatment-resistant epilepsy and are intrinsically epileptogenic for the gelastic seizures that are the hallmark symptom of this disorder. This paper reviews the neuropathologic features of HHs associated with epilepsy, with an emphasis on characterizing neuron phenotypes and an ultimate goal of understanding the cellular model of ictogenesis occurring locally within this tissue. We also present previously unpublished findings on Golgi staining of HH. The microarchitecture of HH is relatively simple, with nodular clusters of neurons that vary in size and abundance with poorly defined boundaries. Approximately 80-90% of HH neurons have an interneuron-like phenotype with small, round soma and short, unbranched processes that lack spines. These neurons express glutamic acid decarboxylase and likely utilize γ-aminobutyric acid (GABA) as their primary neurotransmitter. They have intrinsic membrane properties that lead to spontaneous pacemaker-like firing activity. The remaining HH neurons are large cells with pleomorphic, often pyramidal, soma and dendrites that are more likely to be branched and have spines. These neurons appear to be excitatory, projection-type neurons, and have the functionally immature behavior of depolarizing and firing in response to GABA ligands. We hypothesize that the irregular neuronal clusters are the functional unit for ictogenesis. Further research to define and characterize these local networks is required to fully understand the cellular mechanisms responsible for gelastic seizures. Wiley Periodicals, Inc.
© 2017 International League Against Epilepsy.

Entities:  

Keywords:  Basic mechanisms; Cellular model; Epilepsy; Gelastic seizure; Hypothalamic hamartoma

Mesh:

Year:  2017        PMID: 28591478     DOI: 10.1111/epi.13752

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

Review 1.  Surgical treatment of hypothalamic hamartomas.

Authors:  Pierre Bourdillon; S Ferrand-Sorbet; C Apra; M Chipaux; E Raffo; S Rosenberg; C Bulteau; N Dorison; O Bekaert; V Dinkelacker; C Le Guérinel; M Fohlen; G Dorfmüller
Journal:  Neurosurg Rev       Date:  2020-04-21       Impact factor: 3.042

2.  Epileptic seizures in a heterogeneous excitatory network with short-term plasticity.

Authors:  Chuanzuo Yang; Zhao Liu; Qingyun Wang; Guoming Luan; Feng Zhai
Journal:  Cogn Neurodyn       Date:  2020-03-16       Impact factor: 5.082

3.  Hypothalamic hamartomas in adulthood: Clinical spectrum and treatment outcome-A unicenter experience.

Authors:  Estefanía Conde Blanco; Carla Anciones Martín; Isabel Manzanares; Francisco Gil López; Pedro Roldán; Antonio Donaire; Jordi Rumiá; Mar Carreño
Journal:  Brain Behav       Date:  2019-10-02       Impact factor: 2.708

4.  Image-guided LINAC radiosurgery in hypothalamic hamartomas.

Authors:  Pantaleo Romanelli; Francesco Tuniz; Sara Fabbro; Giancarlo Beltramo; Alfredo Conti
Journal:  Front Neurol       Date:  2022-09-01       Impact factor: 4.086

5.  Anatomical features decide the atypical seizure manifestation of parahypothalamic hamartomas.

Authors:  Chang Liu; Wenhan Hu; Chao Zhang; Zhong Zheng; Xiaoli Yang; Xiu Wang; Jiajie Mo; Zhihao Guo; Xiaoqiu Shao; Kai Zhang
Journal:  Front Neurol       Date:  2022-09-12       Impact factor: 4.086

Review 6.  The Most Common Lesions Detected by Neuroimaging as Causes of Epilepsy.

Authors:  Bożena Adamczyk; Karolina Węgrzyn; Tomasz Wilczyński; Justyna Maciarz; Natalia Morawiec; Monika Adamczyk-Sowa
Journal:  Medicina (Kaunas)       Date:  2021-03-22       Impact factor: 2.430

Review 7.  Hypothalamic Hamartomas: Evolving Understanding and Management.

Authors:  Nathan T Cohen; J Helen Cross; Alexis Arzimanoglou; Samuel F Berkovic; John F Kerrigan; Ilene Penn Miller; Erica Webster; Lisa Soeby; Arthur Cukiert; Dale K Hesdorffer; Barbara L Kroner; Clifford B Saper; Andreas Schulze-Bonhage; William D Gaillard
Journal:  Neurology       Date:  2021-10-04       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.